Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the general population. Overweight is a common condition in patients with NAFLD, and body composition (BC) assessment is useful to evaluate nutritional status and the efficacy of nutritional strategies. A valid tool for assessing BC is dual-energy X-ray absorptiometry (DXA). Adiponectin has been shown to be relevant to the pathogenesis of NAFLD. The aim of this observational study is to define the relationship between the severity of NAFLD, the central fat mass evaluated by DXA, and the circulating levels of adiponectin.
Abenavoli, L., Di Renzo, L., Guzzi, P.h., Pellicano, R., Milic, N., De Lorenzo, A. (2015). Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: A close relationship. CLUJUL MEDICAL, 88(4), 489-493 [10.15386/cjmed-595].
Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: A close relationship
Abenavoli L.;Di Renzo L.;Pellicano R.;Milic N.;De Lorenzo A.
2015-01-01
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the general population. Overweight is a common condition in patients with NAFLD, and body composition (BC) assessment is useful to evaluate nutritional status and the efficacy of nutritional strategies. A valid tool for assessing BC is dual-energy X-ray absorptiometry (DXA). Adiponectin has been shown to be relevant to the pathogenesis of NAFLD. The aim of this observational study is to define the relationship between the severity of NAFLD, the central fat mass evaluated by DXA, and the circulating levels of adiponectin.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
